companydata.dkcompanydata.dk

Asahi Kasei Pharma Denmark A/S: Financial statements 2022

CVR: 40948074

Source: annual report 2022, Danish Business Authority

01/04/2021 – 31/03/2022

Asahi Kasei Pharma Denmark A/S (CVR 40948074) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,216,585 and a net result of DKK 4,670,489. Equity in the 2022 report amounted to DKK 907,659,881. The solvency ratio was 99.5%.

Gross Profit
DKK -1,216,585
Profit/Loss
DKK 4,670,489
Equity
DKK 907,659,881
Total Assets
DKK 912,639,298
Employees
0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Asahi Kasei Pharma Denmark A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About Asahi Kasei Pharma Denmark A/S

Asahi Kasei Pharma Denmark A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named River Forest A/S. The management consists of Daisuke Matsuo. The board consists of Masaya Etoh (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -793,488 and a net result of DKK 25,833,192 compared with DKK 26,072,771 the year before. Equity in the 2026 report amounted to DKK 1,003,291,531.

Source: annual report 2026, Danish Business Authority

Other financial years